Who has invested in Pelage Pharmaceuticals?

ARCH Venture Partners, Google Ventures, Main Street Advisors, Visionary Ventures, YK Bioventures are named among the investors backing Pelage Pharmaceuticals.

Pelage Pharmaceuticals Funding: $154M Raised, Series B

Pelage Pharmaceuticals funding overview

Pelage Pharmaceuticals is a Biotech company based in Los Angeles, California. Pelage Pharmaceuticals has raised $154M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in October 2025. The round record for Pelage Pharmaceuticals runs through 2025; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Google Ventures, Main Street Advisors, Visionary Ventures, YK Bioventures. 5 distinct backers are named across the disclosed rounds.

Pelage Pharmaceuticals at a glance

Total raised: $154M
Latest round: Series B
Latest round date: October 2025
Industry: Biotech
Headquarters: Los Angeles, California
Notable investors: ARCH Venture Partners, Google Ventures, Main Street Advisors, Visionary Ventures, YK Bioventures

Frequently asked about Pelage Pharmaceuticals funding

How much has Pelage Pharmaceuticals raised?: Pelage Pharmaceuticals has raised $154M in total disclosed funding across the rounds on record.
Who has invested in Pelage Pharmaceuticals?: ARCH Venture Partners, Google Ventures, Main Street Advisors, Visionary Ventures, YK Bioventures are named among the investors backing Pelage Pharmaceuticals.
What was the latest Pelage Pharmaceuticals funding round?: The most recent disclosed round is a Series B, announced in October 2025.
Where is Pelage Pharmaceuticals based?: Pelage Pharmaceuticals is based in Los Angeles, California.
What sector does Pelage Pharmaceuticals operate in?: Pelage Pharmaceuticals is tracked under Biotech from Los Angeles, California, with $154M in disclosed funding.
When did Pelage Pharmaceuticals last raise?: The last disclosed Pelage Pharmaceuticals round closed in October 2025 at Series B.

We update the Pelage Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Los Angeles and their backers are listed below.

Pelage Pharmaceuticals Funding: $154M Raised, Series B

Pelage Pharmaceuticals funding overview

Pelage Pharmaceuticals at a glance

Frequently asked about Pelage Pharmaceuticals funding

Pelage Pharmaceuticals founders (1)

Companies related to Pelage Pharmaceuticals (40)

Browse related funding lists (7)